IL-22 and Its Role in Allergic Asthma
Author Information
Author(s): Christian Taube, Christine Tertilt, Gabor Gyülveszi, Nina Dehzad, Katharina Kreymborg, Kristin Schneeweiss, Erich Michel, Sebastian Reuter, Jean-Christophe Renauld, Danielle Arnold-Schild, Hansjörg Schild, Roland Buhl, Burkhard Becher
Primary Institution: Johannes Gutenberg-University, Mainz, Germany
Hypothesis
IL-22 acts as a negative regulator in the development of allergic airway disease.
Conclusion
IL-22 limits airway inflammation and tissue damage in allergic lung disease.
Supporting Evidence
- IL-22 is predominantly produced by innate lymphoid cells in the inflamed lungs.
- IL-22-deficient mice showed significantly higher airway hyperreactivity upon airway challenge.
- Mice treated with IL-22 before antigen challenge displayed reduced airway constriction and inflammation.
Takeaway
IL-22 is a helper molecule that helps keep our lungs healthy when we have allergies, and giving it can help reduce allergy symptoms.
Methodology
The study used murine models of allergic airway inflammation to assess the role of IL-22 in airway hyperreactivity and inflammation.
Limitations
The study primarily used murine models, which may not fully replicate human allergic responses.
Participant Demographics
C57BL/6 mice were used in the study.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website